Comparing post op emergence delirium in children undergoing infraumblical surgery with dexmedetomidine and propofol

Comparison of intravenous infusion of dexmedetomidine and propofol in children undergoing infraumblical surgery under general anaesthesia on the effect of emergence delirium

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/03/031645

Enrollment

Registered

2021-03-01

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 4- Measurement and Monitoring

Interventions

Intervention1: Intravenous infusion with propofol: Intravenous infusion of propofol will be given for the whole duration of surgery at the dose of 0.1mg/kg/min for infraumblical surgeries lasting more

Eligibility

Inclusion criteria

Inclusion criteria: ASA Grade 1&2, Modified Mallampati Grade 1&2, undergoing elective general surgery under general anaesthesia

Exclusion criteria

Exclusion criteria: Patients with any known drug allergy, history of active airway disease, cardiovascular disorder, with developmental delay and surgeries less than 45 minutes

Design outcomes

Primary

Measure	Time frame
To compare incidence of emergence delirium in children undergoing infraumbilical surgery under general anaesthesia by PAEDIATRIC ANAESTHESIA EMERGENCE DELIRIUM SCORE (PAED SCORE) and COLE SCORETimepoint: after extubation and postoperatively	—

Secondary

Measure	Time frame
To assess severity of pain in children undergoing infraumbilical surgery under general anaesthesia by FLACC SCORE , MODIFIED OBJECTIVE PAIN SCORE (MOP SCORE) and to compare the haemodynamic parameters by Heart Rate , Mean blood pressure , SPO2 (pulse oximetry)Timepoint: after extubation and postoperatively	—

Countries

India

Contacts

Public ContactMadhu Dayal

Vardhman Mahavir Medical College and Safdarjung Hospital

drmadhudayal@gmail.com9811271996

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026